Stavros Mercouris

Stavros Mercouris (London) joined KKR in 2014 and is a member of the European Private Equity team focusing on the Health Care sector.
Mr. Mercouris has been actively involved in KKR’s private equity investments in IVI-RMA, GeneraLife, ELSAN, Upfield, and Hensoldt, and the special situations investment in Alvogen.
Prior to joining KKR, he worked at McKinsey & Co. in London where he focused on client work in a range of industries.
Mr. Mercouris holds an M.B.A.
from Harvard Business School, a masters in Finance from Cambridge University and a BSc in Theoretical Physics from Imperial College.